The New Yorker has an intriguing article on Big Pharma's pipeline problem. The idea is that R&D doesn't scale (though how he would explain 3M is a mystery) and that pharmaceutical firms should adopt the current Hollywood studio system, becoming distribution houses and money suppliers.
What really puzzles me is that if it is true, we have a classic case of the parts being greater than the whole and dismemberment would lead to huge profits for any corporate raider willing to take on the challenge. So why aren't there any doing just that?
That one's a real head scratcher.
Posted by TMLutas at February 11, 2004 11:04 PM